Site Injection Reaction, Maculopapular Rash, and Rosacea Exacerbation after COVID-19 Vaccination

Younes Benyamna; Farah Marraha; Ibtissam Al Faker; Hanane Chahoub; Najlae Rahmani; Yasmine Rkiek; Soukayna Kabbou; Driss Soussi Tanani; Salim Gallouj

doi:10.1155/2022/9944727

Site Injection Reaction, Maculopapular Rash, and Rosacea Exacerbation after COVID-19 Vaccination

Case Rep Dermatol Med. 2022 Apr 14:2022:9944727. doi: 10.1155/2022/9944727. eCollection 2022.

Authors

Younes Benyamna^{1

2}, Farah Marraha^{1

2}, Ibtissam Al Faker^{1

2}, Hanane Chahoub^{1

2}, Najlae Rahmani^{1

2}, Yasmine Rkiek^{1

2}, Soukayna Kabbou^{1

2}, Driss Soussi Tanani^{2

3}, Salim Gallouj^{1

2}

Affiliations

¹ Department of Dermatology, University Hospital Center of Tangier, Tetouan, Al Hoceima, Morocco.
² Faculty of Medicine and Pharmacy Tangier, Abdelmalek Essaadi University, Tangier, Morocco.
³ Department of Pharmacology and Pharmacovigilance, University Hospital Center of Tangier, Tetouan, Al Hoceima, Morocco.

Abstract

To date, the occurrence of adverse events following immunization after COVID-19 vaccine is rare, and their report is still very poor; however, causality assessment is conducted to identify the associated cause, if they occur. In this case report, we present a case of an association of three cutaneous manifestations (maculopapular exanthem with enanthem, site injection reaction, and rosacea exacerbation) occurring three days after taking the first dose of AstraZeneca AZD1222 vaccine.

Publication types

Case Reports